ARTICLES BY LOUIS

• “Who Are They?” A Biotech CEO's Timeless Question For CDMOs

  4/20/2020

  The questions James E. Brown, President & CEO, DURECT, asked of CDMOs when he founded the company in 1998 remain perfectly operational: "Who are they? Where did those individuals come from? What are their personal track records?”

• “Political” Supply-Chain Decisions In Time Of Crisis

  4/16/2020

  At this time of difficult political, economic, and health-related decision-making, the entire nation needs your practiced mix of data centrality, and your experience in partnerships and (supply-chain) systems where qualitative analysis also play a major role.

• Shared Responsibility: A Millennial's Outsourcing Strategy

  4/15/2020

  We featured Sara McCutchan in an earlier editorial, "A Path To Biotech For Young Women." Here she provides strong examples and best practices for small biotechs reliant on outsourcing drug development to CDMOs.

• Inserting The Pharmacist At The Center Of Biopharma

  4/8/2020

  The president of a college of pharmacy believes pharmacy graduates should occupy the center of the biopharma drug development and manufacturing industry. In fact, quite a few do already. More are on the way.

• Sign The “50 By 25” Declaration Of Drug Independence

  4/2/2020

  Will you become a founding signatory to the aggressive but realistic, "U.S. '50 By 25' Declaration Of Drug Independence"? And dedicate yourself to the goal of reducing dependency on foreign sources for drug materials, intermediates, substances?

• A Biopharma Life: From An Indian Village To A San-Diego Super Cluster

  4/1/2020

  A non-coronavirus-related editorial perfect for this time. Now more than ever, we recognize the value of individuals. Part 2 of our narrative with BMS's Brahmachary Enugurthi.

• When Employees Become The Supply Chain: Leadership In A Pandemic

  3/30/2020

  With your newly dispersed workforce, employees have in effect become a part of your external supply chain. How can leaders help them get through this time of uncertainty, and continue to perform at a high level? Here's some advice.

• Biopharma Answers Supply-Chain Questions Raised By COVID-19

  3/26/2020

  In terms of increasing transparency regarding the location of production, Novartis, Regeneron, GeoVac, and Gilead are positive examples for Outsourced Pharma readers.

• 3 Questions Of Risk And Communication In A Time Of Coronavirus

  3/20/2020

  Communication with your service providers may turn out most important in getting through immediate coronavirus-induced supply-chain challenges. Outsourcing may have got you into this situation; now it may be the only thing that can get you out. 

• Beck Joins Boston Pharmaceuticals: Another Sign Of The Times

  3/18/2020

  Celgene and Shire former executive Joanne Beck joins Boston Pharmaceuticals. It's another example of where drug development is heading, and how outsourcing -- and lots of funding -- are driving programs to proof-of-concept.